Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
with dual 503A/503B licensing and massive GLP-1 production capacity Key Strengths: Dual 503A and 503B registered facility enabling both patient-specific and bulk compounding at scale One of the first pharmacies to offer compounded semaglutide with full potency verification and published COAs State-of-the-art 140,000 sq ft FDA-registered facility in Houston with dedicated cleanroom suites Extensive tirzepatide and semaglutide formulations including sublingual and injectable options Notable: Empower processes over 100,000 semaglutide prescriptions monthly, making them the single largest volume compounder of GLP-1 therapies in the nation
Dosing considerations after a storage incident If you have decided your semaglutide is still safe to use after being left out overnight, your dosing schedule should not change
This has implications for inventory management, staffing, and dispensing timelines
Acknowledgements A list of study investigators is available in the Supplementary Information
Gallbladder disease risk increases with rapid weight loss regardless of method used
